Last reviewed · How we verify
dHAM
At a glance
| Generic name | dHAM |
|---|---|
| Sponsor | German Centre for Assessment and Evaluation of Innovative Techniques in Medicine |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers (NA)
- Application of Dried Human Amnion Graft to Improve Postprostatectomy Incontinence and Potency (PHASE2, PHASE3)
- Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dHAM CI brief — competitive landscape report
- dHAM updates RSS · CI watch RSS
- German Centre for Assessment and Evaluation of Innovative Techniques in Medicine portfolio CI